Evidence map›Paper›PMID 21824271›Full record

ArticleAging cell2011

Age-related decline in osteoblastogenesis and 1α-hydroxylase/CYP27B1 in human mesenchymal stem cells: stimulation by parathyroid hormone.

Shuo Geng, Shuanhu Zhou, Julie Glowacki

Open access · bronzeAbstract read
In one paragraph

Article in Aging cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.The Journal of clinical endocrinology and metabolism · 2022
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Vitamin D Metabolism Revised: Fall of Dogmas.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2019
    Review
  10. Article
  11. Adrenocorticotropic hormone and 1,25-dihydroxyvitamin DLaboratory investigation; a journal of technical methods and pathology · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Shuo GengDepartment of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Shuanhu Zhou
Julie Glowacki
Brigham and Women's Hospital · US

Funding

Effect of Aging &Vitamin D Status on OsteoblastogenesisR01AG025015 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLOWACKI, JULIANNE · 2004 to 2008
$1.9M
EFFECTS OF AGE ON SIGNALING IN HUMAN OSTEOBLASTOGENESISR01AG028114 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLOWACKI, JULIANNE · 2007 to 2010
$1.1M
NIA NIH HHS R01 AG025015NIA NIH HHS R01 AG028114
6 · The paper itself

Abstract

With aging, there is a decline in bone mass and in osteoblast differentiation of human mesenchymal stem cells (hMSCs) in vitro. Osteoblastogenesis can be stimulated with 1,25-dihydroxyvitamin D(3) [1,25(OH)(2) D(3) ] and, in some hMSCs, by the precursor 25-hydroxyvitamin D(3) (25OHD(3) ). CYP27B1/1α-hydroxylase activates 25OHD(3) and, to a variable degree, hMSCs express CYP27B1. In this study, we tested the hypotheses (i) that age affects responsiveness to 25OHD(3) and expression/activity of CYP27B1 in hMSCs and (ii) that parathyroid hormone (PTH) upregulates CYP27B1 in hMSCs, as it does in renal cells. There were age-related declines in osteoblastogenesis (n=8, P=0.0286) and in CYP27B1 gene expression (n=27, r= -0.498; P=0.008) in hMSCs. Unlike hMSCs from young subjects (≤50 years), hMSCs from older subjects (≥55 years) were resistant to 25OHD(3) stimulation of osteoblastogenesis. PTH1-34 (100 nm) provided hMSCs with responsiveness to 25OHD(3) (P=0.0313, Wilcoxon matched pairs test) and with two episodes of increased 1,25(OH)(2) D(3) synthesis, of cAMP response element binding protein (CREB) activation, and of CYP27B1 upregulation. Both increases in CYP27B1 expression by PTH were obliterated by CREB-siRNA or KG-501 (which specifically inhibits the downstream binding of activated CREB). Only the second period of CREB signaling was diminished by AG1024, an inhibitor of insulin-like growth factor-I receptor kinase. Thus, PTH stimulated hMSCs from elders with responsiveness to 25OHD(3) by upregulating expression/activity of CYP27B1 and did so through CREB and IGF-I pathways.

Indexed as

Aging25-Hydroxyvitamin D3 1-alpha-HydroxylaseAdultAgedBlotting, WesternCalcifediolCell DifferentiationCyclic AMP Response Element-Binding ProteinEnzyme InhibitorsGene Expression Regulation, EnzymologicHumansInsulin-Like Growth Factor IMesenchymal Stem CellsNaphtholsOrganophosphatesOsteoblasts1,25-dihydroxyvitamin D25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcifediolCREB1 protein, humanCyclic AMP Response Element-Binding ProteinEnzyme InhibitorsInsulin-Like Growth Factor Inaphthol AS-E phosphateNaphtholsOrganophosphatesParathyroid HormoneRNA, Small InterferingSteroid Hydroxylasestyrphostin AG 1024TyrphostinsVitamin D

Identifiers

PMID21824271
PMCPMC3215854
OpenAlexW1489948920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.